Colin Kellaher

6 days ago | tradingview.com | Colin Kellaher

Regeneron, Sanofi Get FDA Approval For Dupixent in Skin Disease CSUSANREGNRegeneron Pharmaceuticals and Sanofi won U.S. Food and Drug Administration expanded approval of their blockbuster anti-inflammatory drug Dupixent for the inflammatory skin condition chronic spontaneous urticaria, or CSU. Regeneron and Sanofi on Friday said the approval covers Dupixent in people 12 and older who have CSU and remain symptomatic despite histamine-1 antihistamine treatment.

6 days ago | tradingview.com | Colin Kellaher

TD Bank's Schwab Investment to Contribute C$74 Million to Bank's 2QTDToronto-Dominion Bank's stake in Charles Schwab will translate into about 74 million Canadian dollars ($53.5 million) of reported equity in net income of an investment in the bank's fiscal second quarter.

1 week ago | wsj.com | Colin Kellaher

Lockheed Martin’s top finance executive, Jesus “Jay” Malave, is leaving the defense giant to pursue other opportunities. Lockheed on Thursday said veteran finance executive Evan Scott succeeds Malave as senior vice president and chief financial officer, effective immediately. Lockheed named Malave chief financial officer in February 2022, recruiting the executive from smaller rival L3Harris Technologies in a rare transfer between two of the U.S.’s prime defense contractors.

1 week ago | marketscreener.com | Colin Kellaher

By Colin Kellaher Regeneron Pharmaceuticals has won U.S. Food and Drug Administration priority review for its application seeking expanded approval of its Eylea HD eye drug. Regeneron on Thursday said the application covers Eylea HD for the treatment of macular edema following retinal vein occlusion and for broadening the dosing schedule to include monthly dosing across approved indications.

1 week ago | marketscreener.com | Colin Kellaher

By Colin Kellaher Lyft agreed to buy European taxi-hailing app Freenow from German automakers BMW and Mercedes-Benz for about 175 million euros ($197.4 million) in cash, marking the ride-hailing giant's first expansion beyond bikes and scooters outside of North America. Lyft on Tuesday said the deal, which it plans to fund with cash on hand, increases annualized gross bookings by about $1.1 billion and supports its target of delivering roughly $25 billion of gross bookings in 2027.